The global skin excision market involves procedures to remove skin lesions, moles or other abnormal skin growths. Skin excision is a minor surgical procedure performed to remove damaged, diseased or unwanted skin. It is commonly used to treat skin cancers like basal cell carcinoma and squamous cell carcinoma. The rising incidence of skin cancers due to increased ultraviolet radiation exposure from the sun is a key factor driving demand for skin excision procedures.

The Global skin excision market is estimated to be valued at US$ 29.9 BN in 2024 and is expected to exhibit a CAGR of 9.0% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in The Global Skin Excision Market are Ethicon Inc., Richard Wolf GMBH, Becton, Dickinson and Company, Integra LifeSciences, Exsurco Medical, Limbs & Things LTD, KARL STORZ GmbH & Co. KG, Aesculap, Inc., Medtronic, Zimmer Biomet, B. Braun SE, Conmed Corporation, Symmetry Surgical Inc., and Surtex Instruments Limited. These players are focusing on new product launches and geographical expansion to gain market share.

The key opportunities in the global skin excision market include rising medical tourism in developing countries for skin cancer treatment and increasing adoption of minimally invasive procedures. Additionally, growing geriatric population that is more susceptible to non-melanoma skin cancers will drive market growth.

Globally, the skin excision market is expanding rapidly as key players focus on emerging markets in Asia Pacific and Latin America. Favorable government initiatives and improving access to healthcare in these regions is supporting the market expansion.

Market drivers
Increasing incidence of skin cancers driven by growing UV exposure from the sun is a major driver for the skin excision market. According to the International Agency for Research on Cancer, over 3 million new cases of non-melanoma skin cancer are diagnosed globally each year. Rising awareness about early detection and treatment of skin cancers is also supporting market growth. Additionally, technological advancements enabling minimally invasive procedures and faster recovery times are fueling demand for skin excision.

Market restraints
High cost of treatment for skin excision procedures inhibits market growth in price-sensitive regions. Lack of reimbursement policies related to cosmetic procedures in some countries also poses a restraint. Additionally, few alternative treatment options such as photodynamic therapy or chemotherapy pose competitive threats to traditional excisional methods.

Segment Analysis
The global skin excision market is dominated by the moles excision sub segment. Moles are common skin growths that can appear anywhere on the body like face, back etc. According to various studies, it has been found that around one-third of adults have moles on their skin. Some moles, especially atypical or dysplastic moles, have a higher risk of becoming melanoma. Therefore, as a precautionary measure, most people prefer getting moles examined and removed through excision process if found suspicious. This large patient pool undergoing routine mole checks and subsequent excisions if required has made mole excision the dominating sub segment in the global skin excision market.

Global Analysis
Regionally, North America is the fastest growing as well as dominating regional market for skin excision. High awareness levels regarding skin cancer, established healthcare infrastructure and high disposable incomes in countries like US and Canada are major factors responsible for North America's leading position. Europe also captures a significant market share owing to rising melanoma incidence and supportive government funding for cancer treatment in major countries like Germany, UK and France. However, Asia Pacific region is emerging as the most lucrative market for skin excision given factors like rapidly ageing population, increased healthcare spending and growing medical tourism in countries like India, China and Singapore.

Get More Insights On Global Skin Excision Market